Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial

Patrick Most1, Hanna Seifert, Erhe Gao

  • 1Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA. patrick.most@jefferson.edu

Circulation
|September 6, 2006
PubMed

Insights

Reduced S100A1 protein in the heart worsens heart failure after myocardial infarction. Increasing S100A1 levels protects cardiac function and improves survival in heart failure models.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Diminished S100A1 protein is observed in human cardiomyopathies.
  • S100A1 is a calcium-dependent inotropic factor in the heart.

Purpose of the Study:

  • To investigate the role of S100A1 protein levels in the development and progression of post-ischemic heart failure (HF).

Main Methods:

  • S100A1-transgenic (STG) and S100A1-knockout (SKO) mice underwent myocardial infarction (MI).
  • Cardiac function, remodeling, apoptosis, and survival were compared between STG, SKO, nontransgenic littermate control (NLC), and wild-type (WT) mice up to 4 weeks post-MI.

Main Results:

  • S100A1-deficient hearts (SKO-MI) showed acute contractile decompensation, accelerated HF progression, increased apoptosis, and higher mortality.
  • S100A1-overexpressing hearts (STG-MI) demonstrated preserved cardiac function, reduced apoptosis, and prevention of hypertrophy and HF, with superior survival.
  • Signaling pathways (Gq, Gs, PKC) influenced cardiac S100A1 levels, impacting sarcoplasmic reticulum Ca2+ cycling and beta-adrenergic signaling.

Conclusions:

  • Downregulation of S100A1 protein critically contributes to cardiac contractile dysfunction in heart failure.
  • S100A1 levels are a key determinant of the clinical course in patients with heart failure.
Abstract

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
2.2K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805